Interest of molecular/crystalline dispersions for the determination of solubility curves of drugs into polymers
Authors:
- 1 October 2019
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 570, 118626
Abstract
No abstract availableKeywords
Funding Information
- Interreg
This publication has 32 references indexed in Scilit:
- A New Protocol To Determine the Solubility of Drugs into Polymer MatrixesMolecular Pharmaceutics, 2013
- Assessing the performance of amorphous solid dispersionsJournal of Pharmaceutical Sciences, 2012
- Stability of Amorphous Pharmaceutical Solids: Crystal Growth Mechanisms and Effect of Polymer AdditivesThe AAPS Journal, 2012
- Solubility Advantage of Amorphous Drugs and Pharmaceutical CocrystalsCrystal Growth & Design, 2011
- Solubilities of Crystalline Drugs in Polymers: An Improved Analytical Method and Comparison of Solubilities of Indomethacin and Nifedipine in PVP, PVP/VA, and PVAcJournal of Pharmaceutical Sciences, 2010
- Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysisJournal of Pharmaceutical Sciences, 2010
- Solid State Amorphization of PharmaceuticalsMolecular Pharmaceutics, 2008
- New form discovery for the analgesics flurbiprofen and sulindac facilitated by polymer‐induced heteronucleationJournal of Pharmaceutical Sciences, 2007
- Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdvanced Drug Delivery Reviews, 2007
- Formation of molecular alloys by solid-state vitrificationThermochimica Acta, 2000